United Nations/Geneva: The technical advisory group of the World Health Organisation (WHO) sought “additional clarifications” from Bharat Biotech on Tuesday for its COVID-19 vaccine Covaxin to conduct a final “risk-benefit assessment” for the vaccine’s Emergency Use Listing.
The WHO technical advisory group will again meet on November 3 for a final assessment.
Covaxin manufacturer Hyderabad-based Bharat Biotech had submitted EOI (Expression of Interest) to the WHO on April 19 for the vaccine’s Emergency Use Listing (EUL).
The technical advisory group met on Tuesday to review data on Covaxin for the emergency use listing.
“The TAG met today (26 October 2021) and decided that additional clarifications from the manufacturer are needed to conduct a final EUL risk-benefit assessment for global use of the vaccine,” the WHO was quoted as saying by news agency PTI.
“The TAG expects to receive these clarifications from the manufacturer by the end of this week, and aims to reconvene for the final risk-benefit assessment on Wednesday, 3 November,” WHO added.
ALSO READ: Will WHO Finally Approve Covaxin Today?
Surat: Konark Suryas Odisha (KSO) are bracing up for their next challenge in the Legends…
Bhubaneswar: Cockroach omelette! How repulsive does that sound? Imagine the plight of the Air India…
Bargarh: A man was allegedly hacked to death over old rivalry in Odisha's Bargarh district…
Bhubaneswar: Ollywood superstar Sabyasachi Mishra has put on nearly 25 kg for his upcoming film…
Berhampur: To enhance workforce skills and ensure meter integrity, TP Southern Odisha Distribution Limited (TPSODL)…
Bhubaneswar: The nursing staff of government hospitals in Odisha have agreed to call off their…
New Delhi: Union Agriculture & Farmers Welfare Minister Shivraj Singh Chouhan on Saturday laid the…
New Delhi: As Israel continued their attacks on Lebanon for the fifth day, they managed to…